Japanese Doctor Recommends Re-evaluating Approved Vaccines

A Japanese paper by K. Yamamoto titled “Need for validation of vaccination programs” published on 14 March 2025 is a brief commentary on the current vaccination program as well as the current system that evaluates vaccine-related adverse events and deaths.

The paper is 6 pages long and is a quick and easy read.

The motivations of this paper are adverse events and deaths not only due to the recent mRNA vaccines but also the routine and live-attenuated vaccines. For example, regarding COVID-19:

In Japan, excess deaths since the onset of vaccination have exceeded 600,000, though the exact cause remains contentious. The cause of excess deaths cannot be explained solely by corona-related deaths or an aging population, and the increase in vaccine-related deaths may be a significant factor. Similar trends are observed in other countries with intensive vaccination programs.

As for routine vaccinations, the author cites three children who died within a day of administration in late 2023 and early 2024.

In one case, a 2-month-old boy became ill 30 min after receiving simultaneous doses of Hemophilus influenzae type b, rotavirus, and pneumococcal vaccines. He went into asystole in the hospital 59 min later and died the next day. … Additionally, a 6-month-old child who received seven different vaccines (hepatitis B; Hemophilus influenzae type b; pneumococcus; and a combined four-in-one vaccine for pertussis, diphtheria, tetanus, and polio) and a 3-year-old child vaccinated against Japanese encephalitis both died the day after vaccination.

The current system in place, however, seemingly ignores the obvious temporal link.

Despite the availability of detailed reports and autopsies, experts classified all three cases as γ (evaluation not possible), similar to assessments of deaths following coronavirus vaccinations.

Dr Yamamoto then comments on the merits of vaccination. For example, he mentions the potential safety issues with multiple and simultaneous vaccinations. But perhaps the most interesting point is the fundamental issue of how the human body produces useful antibodies.

The human immune system is remarkably complex, with many mechanisms still not fully understood. The production of immunoglobulins (antibodies) is inherently limited, and vaccination with a specific antigen does not substantially increase the immune system’s overall capacity. Humans coexist with a vast array of microorganisms, including over 1,000 types of commensal bacteria, fungi, and viruses. This symbiotic relationship requires constant renewal of immunity. It is worth considering whether the acquisition of immunity through vaccination, which prioritizes the production of one type of antibody (e.g., as seen with coronavirus vaccines), might inadvertently reduce the production of others. As many viruses and bacteria are transmitted through mucous membranes, the current method of directly injecting vaccines into the body bypasses natural immune pathways. As vaccines are administered to healthy individuals, their safety is paramount to ensure they do not contribute to disease or mortality.

In other words, one needs to take a more holistic view when it comes to immunity.

The author also gives the reminder that “Japan is the only country globally to have approved a self-amplifying RNA vaccine” before concluding, amongst other things, to:

“re-evaluate the risks and benefits of the currently approved vaccines”.
reassess the department involved in the evaluation and licensing of vaccines, including its members who may have conflicts of interest.
consider “temporarily suspending the current vaccination program to determine the full extent of potential harm”.